Publication | Open Access

Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease

Medicinal ChemistryAlzheimer's DiseaseNovel Tacrine-hydroxyphenylbenzimidazole HybridsMedicineRational Drug DesignNeuropharmacologyNeurochemical BiomarkersPharmacotherapyNeurologyDrug DevelopmentPharmacologyDrug Discovery